The Neotropix Board of Directors is composed of a group of skilled industry
leaders who have extensive experience and expertise in the life sciences
industry.
|
Neotropix Board of Directors
The board brings together individuals with diverse industry backgrounds that
include research and development, clinical development and venture capital/ investing.
The board's collective knowledge ensures the continuous growth and advancement
of Neotropix.
Our board members are listed below. Please click on the name of each member to
view their background and qualifications.
Peter
Lanciano, CEO
Neotropix
|
| |
|
Paul
Hallenbeck, Ph.D., Founder and CSO
Neotropix
|
| |
|
Sena K.
Biswas, Ph.D, Managing Director, Life Sciences
VIMAC Ventures
|
| |
|
Chris Kroeger, M.D. Partner
Aurora
Funds |
| |
|
Dennis
L. Panicali, Consultant
Neotropix |
| |
|
Matthew
Rieke, M.D., Partner
Quaker
BioVentures |
| |
|
| |
|
|
